Skip to main content

Drugs Made In America Acquisition Corp.

DMAA
Exchange
Nasdaq
Industry
Blank Checks
SEC CIK
0002028614

No open-market purchases or sales by Drugs Made In America Acquisition Corp. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $145.8M in total; no superinvestor holds it.

Other share classesDMAARDMAAU

13F holders, Q2 2026

Institutional positions in Drugs Made In America Acquisition Corp. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
23
−16 vs. Q1 2026
Shares held
14.0M
−8.91M (−38.9%) vs. Q1 2026
Total value
$145.8M
−$91.6M (−38.6%) vs. Q1 2026
New holders
1
3 more added
Sold out
17
15 more reduced

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting DMAA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 23 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 24 institutionsQ2 2025: 32 institutionsQ3 2025: 37 institutionsQ4 2025: 39 institutionsQ1 2026: 39 institutionsQ2 2026: 23 institutions
Value heldQ2 2026: $145.8M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $171.3MQ2 2025: $212.3MQ3 2025: $224.5MQ4 2025: $232.1MQ1 2026: $237.3MQ2 2026: $145.8M
Institutions holding DMAA and their total value by quarter
QuarterHoldersValue
Q2 202623$145.8M
Q1 202639$237.3M
Q4 202539$232.1M
Q3 202537$224.5M
Q2 202532$212.3M
Q1 202524$171.3M
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Drugs Made In America Acquisition Corp.; share changes are against Q1 2026.

Institutions holding DMAA in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Mizuho Securities USA LLC4,069,605$42.8M0.41%+2,069,605+103.5%Added
Karpus Management, Inc.2,507,817$26.7M0.77%−22,700−0.9%Reduced
Polar Asset Management Partners Inc.1,146,000$12.2M0.22%−454,000−28.4%Reduced
Glazer Capital, LLC999,899$10.6M0.26%−678,507−40.4%Reduced
Wolverine Asset Management LLC832,093$8.86M0.12%−721,615−46.4%Reduced
Highbridge Capital Management LLC809,054$8.62M0.29%−514,297−38.9%Reduced
Vivaldi Asset Management, LLC786,459$8.38M0.49%−1,456,041−64.9%Reduced
Heights Capital Management, Inc648,083$6.90M1.59%−1,917−0.3%Reduced
Westchester Capital Management, LLC581,790$6.20M0.31%−1,087,210−65.1%Reduced
Aristeia Capital LLC350,000$3.73M0.06%−531,716−60.3%Reduced
Sona Asset Management (US) LLC162,795$1.73M0.06%00.0%Unchanged
Clear Street Group Inc.382,440$1.65M0.01%+28,392+8.0%Added
RLH Capital LLC115,606$1.23M0.59%−200,945−63.5%Reduced
Logan Stone Capital, LLC109,959$1.17M0.25%+109,959New
Toronto Dominion Bank100,000$1.06M0.00%−103,838−50.9%Reduced
Meteora Capital, LLC97,837$1.04M0.09%−282,462−74.3%Reduced
Quarry LP65,551$698.1K0.11%−201,000−75.4%Reduced
Geode Capital Management, LLC62,273$663.2K0.00%00.0%Unchanged
JPMorgan Chase & Co49,891$531.3K0.00%+100.0%Added
Dakota Wealth Management36,400$387.7K0.01%00.0%Unchanged
Lineage Point Capital LP31,840$339.1K0.07%00.0%Unchanged
HRT Financial LP18,483$196.0K0.00%−9,004−32.8%Reduced
Morgan Stanley28$2980.00%−30−51.7%Reduced
D. E. Shaw & Co., Inc.0$00.00%−690,000−100.0%Sold out
Shaolin Capital Management LLC0$00.00%−550,000−100.0%Sold out
Radcliffe Capital Management, L.P.0$00.00%−546,808−100.0%Sold out
LMR Partners LLP0$00.00%−500,000−100.0%Sold out
Rivernorth Capital Management, LLC0$00.00%−417,998−100.0%Sold out
Whitebox Advisors LLC0$00.00%−400,000−100.0%Sold out
CNH Partners LLC0$00.00%−357,585−100.0%Sold out
Hudson Bay Capital Management LP0$00.00%−297,833−100.0%Sold out
Context Capital Management, LLC0$00.00%−250,000−100.0%Sold out
Governors Lane LP0$00.00%−250,000−100.0%Sold out
L1 Global Manager Pty Ltd0$00.00%−200,000−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−119,686−100.0%Sold out
DLD Asset Management, LP0$00.00%−100,559−100.0%Sold out
Warberg Asset Management LLC0$00.00%−92,054−100.0%Sold out
Periscope Capital Inc.0$00.00%−50,000−100.0%Sold out
BNP Paribas Arbitrage, SA0$00.00%−14,737−100.0%Sold out
Citadel Advisors LLC0$00.00%−10,476−100.0%Sold out